Clinical Trial Update: Phase II, Dose Finding Study of GTx-758 [Phase 2]

View source ↗

Summary

Phase II dose-finding study of GTx-758 in prostate cancer was terminated; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GTx-758

Snippet

Sponsor: GTx | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-04-22